AGC Biologics doubles mammalian capacityWith a new expansion coming online in Copenhagen, AGC Biologics is offering more capacity in Europe for mammalian biologics projects using innovative single-use bioreactor technology. This is the latest … more ➔
Unleashing the power of LNP encapsulationThe Covid-19 pandemic has changed perception of the value of rapid vaccine production, followed by multi-billion investments across the globe. While nanomedicines are receiving attention for enhancing … more ➔
Cells: The heart of Biovians rAAV manufa...Viral Vectors?Commercial-scale manufacturing demands a high yield of potent rAAV products. Understanding the metabolism during cell growth, especially at high densities, molecular effects of transfection … more ➔
Vector BioPharma: the future of gene deliv...Precision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge and, with cutting-edge technology from … more ➔
Crossing the commercialisation chasmAs a late-stage investor focusing on the European bioeconomy, the ECBF is carefully assessing the maturity of any technology, but more important than maturity is the ability to reach commercial scale. … more ➔
CDMOCDMO excellence in phytocannabinoid produc...CB21 Pharma Ltd announces that it entered a global strategic collaboration to combineits leading expertise and clinical research program in phytocannabinoids with world-classpharmaceutical strategic … more ➔
Sourcing innovation in the Life Sciences s...BioFIT is Europes leading partnering event in Life Sciences for tech transfer, early-stage innovation deals and pre-seed, seed and Series A investment, receiving each year more than 1,000 delegates … more ➔
Pulsating biotech locationTakeda, Boehringer Ingelheim and Novartis do it repeatedly. Global players make major investments in their Austrian facilities. Not only multinationals but start-ups and scale-ups such as Apeiron … more ➔
Reliable medical-grade refrigeratorsKeeping biologicals at low temperatures is an established and effective way of maintaining their potency. This is critical for many types of medicines, vaccines, reagents, and biological samples, which … more ➔
The pharma lab in times of cell & gen...After two years online, PharmaLab 2022 returns on site for its 10th edition. Over three days, the congress will offer the opportunity to share the latest experiences with colleagues and to exchange … more ➔